Features | Partner Sites | Information | LinkXpress
Sign In
Ampronix
KOREA E & EX
Schiller

Noncompliant Coronary Balloon Helps Navigate Tortuous Anatomy

By HospiMedica International staff writers
Posted on 16 Jun 2014
Image: The NC Euphora noncompliant balloon dilatation catheter with tapered tip (Photo courtesy Medtronic).
Image: The NC Euphora noncompliant balloon dilatation catheter with tapered tip (Photo courtesy Medtronic).
A new noncompliant coronary balloon provides superior deliverability and controlled growth in challenging angioplasty procedures.

The NC Euphora Noncompliant Balloon Dilatation Catheter offers enhanced deliverability through tight lesions via proprietary PowerTrac technology, thus requiring less force application to provide tracking through tortuous anatomy. An optimized tapered tip design and low lesion entry profile improve flexibility and allow for reliable stent re-cross when traversing long, challenging lesions, so that the balloon does not catch on a strut when passing through a deployed stent.

The balloon is made of strong, durable, and flexible Low Inflation Growth, High Track (LIGHT) material that provides high pressure capability, enabling the NC Euphora to expand consistently within the stent area at a rated burst pressure—the maximum pressure that the balloon can be repeatedly inflated in a safe manner—of up to 20 atmospheres without bursting. Significantly low radial growth reduces unwanted vessel expansion and longitudinal growth beyond the stent length, minimizing damage to the surrounding healthy artery. The NC Euphora Noncompliant Balloon Dilatation Catheter is a product of Medtronic (Minneapolis, MN, USA).

“NC Euphora expands our interventional portfolio with another clinically-relevant tool that was developed with both interventionalists and cath lab teams' needs in mind,” said Jason Weidman, vice president and general manager of Medtronic's coronary business. “With the addition of a premium noncompliant balloon, our interventional customers have a complement to the other innovative Medtronic offerings throughout the entire procedure for their most difficult and challenging cases.”

“When using a noncompliant balloon, deliverability and re-cross are important characteristics, especially when faced with challenging coronary anatomy,” said consultant interventional cardiologist Robert Gerber, MD, PhD, of Eastbourne District General Hospital East Sussex Healthcare NHS Trust, and preclinical researcher for the NC Euphora balloon. “The NC Euphora balloon was designed to meet these demands and provide reliable performance with no tradeoffs in the moment that we need it most.”

Related Links:

Medtronic
Eastbourne District General Hospital East Sussex Healthcare NHS Trust



JD Honigberg International
Inditherm
Harloff

Channels

Critical Care

view channel

Little Evidence Supports Opioid Use for Chronic Pain

A new study reveals that there is paltry evidence for the long-term safety and efficacy of opioids in the treatment of chronic pain. Researchers at the Oregon Health & Science University (OHSU; Portland, USA) and the University of Washington (Seattle, USA) searched MEDLINE, the Cochrane Central Register of Controlled... Read more

Women's Health

view channel

Pregnant Women in Austria Experience Iodine Deficiency

A new study suggests that pregnant women in Austria have a potentially clinically significant iodine deficiency which could impair embryonic brain development. Researchers at the Medical University of Vienna (Austria) conducted a cross-sectional investigation of urinary iodine excretion in 246 pregnant women (2 in the... Read more

Health IT

view channel

Computer Model Predicts Public Response to Disease Outbreaks

A new computer model could help public health officials anticipate public reactions to disease outbreaks, based on a combination of data collected from hospitals, social media, and other sources. Researchers at MIT (Cambridge, MA, USA), the Draper Laboratory (Cambridge, MA, USA), and Ascel Bio (Larchmont, NY, USA),... Read more

Business

view channel

Abbott Completes Topera Acquisition

Abbott (Abbott Park, IL, USA) has completed its acquisition of Topera (Menlo Park, CA, USA), developer of innovative electrophysiology technologies for the diagnosis and treatment of atrial fibrillation (AF). The Topera rotor identification system helps physicians identify and target patient-specific rotors that have... Read more
 

Events

05 Mar 2015 - 08 Mar 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.